| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |